Stanford Cancer Institute — Stanford, California

Stanford Cancer Institute is a clinical research site located in Stanford, California, United States 93405.

Crixeo Health Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.

Stanford Cancer Institute has participated in 60 clinical trials with 20 currently active.

Therapeutic areas: Metastatic Malignant Solid Neoplasm, Metastatic Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8.

Sponsors: Anusha Kalbasi, Clovis Oncology, Inc., Galera Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 86/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Stanford Cancer Institute?

Stanford Cancer Institute has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Stanford Cancer Institute conducted?

Stanford Cancer Institute has 60 clinical trials on record, with 20 currently active. Their work covers Metastatic Malignant Solid Neoplasm, Metastatic Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8.

Is Stanford Cancer Institute accredited by Crixeo Health?

Yes — Stanford Cancer Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Stanford Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.